iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$89.67−1.16 (-1.28%)
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
iRhythm total assets
Total assets on the balance sheet at the end of each period.
iRhythm's total assets was $1.09B at Jun 30, 2026. For fiscal 2025 it was $1.02B, up 9.5% from the year before. Over ten years it grew 39.0% a year on average. The highest annual figure on record is $1.02B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | +9.5% |
| FY2024 | Dec 31, 2024 | $931.45M | +115.0% |
| FY2023 | Dec 31, 2023 | $433.14M | -3.4% |
| FY2022 | Dec 31, 2022 | $448.22M | -3.2% |
| FY2021 | Dec 31, 2021 | $462.97M | -9.5% |
| FY2020 | Dec 31, 2020 | $511.74M | +67.1% |
| FY2019 | Dec 31, 2019 | $306.21M | +160.6% |
| FY2018 | Dec 31, 2018 | $117.52M | -11.9% |
| FY2017 | Dec 31, 2017 | $133.38M | -3.5% |
| FY2016 | Dec 31, 2016 | $138.16M | +264.8% |
| FY2015 | Dec 31, 2015 | $37.87M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.09B | +13.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.01B | +8.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.02B | +9.5% |
| Q3 FY2025 | Sep 30, 2025 | $995.21M | +9.4% |
| Q2 FY2025 | Jun 30, 2025 | $964.03M | +4.9% |
| Q1 FY2025 | Mar 31, 2025 | $926.10M | +1.8% |
| Q4 FY2024 | Dec 31, 2024 | $931.45M | +115.0% |
| Q3 FY2024 | Sep 30, 2024 | $909.69M | +106.9% |
| Q2 FY2024 | Jun 30, 2024 | $919.19M | +114.0% |
| Q1 FY2024 | Mar 31, 2024 | $909.76M | +115.7% |
| Q4 FY2023 | Dec 31, 2023 | $433.14M | -3.4% |
| Q3 FY2023 | Sep 30, 2023 | $439.77M | -0.1% |
| Q2 FY2023 | Jun 30, 2023 | $429.49M | -1.4% |
| Q1 FY2023 | Mar 31, 2023 | $421.70M | -1.6% |
| Q4 FY2022 | Dec 31, 2022 | $448.22M | -3.2% |
| Q3 FY2022 | Sep 30, 2022 | $440.39M | -8.3% |
| Q2 FY2022 | Jun 30, 2022 | $435.69M | -10.2% |
| Q1 FY2022 | Mar 31, 2022 | $428.72M | -10.4% |
| Q4 FY2021 | Dec 31, 2021 | $462.97M | -9.5% |
| Q3 FY2021 | Sep 30, 2021 | $480.25M | -3.4% |
| Q2 FY2021 | Jun 30, 2021 | $485.22M | +75.7% |
| Q1 FY2021 | Mar 31, 2021 | $478.49M | +69.1% |
| Q4 FY2020 | Dec 31, 2020 | $511.74M | +67.1% |
| Q3 FY2020 | Sep 30, 2020 | $497.20M | +60.3% |
| Q2 FY2020 | Jun 30, 2020 | $276.22M | +34.6% |
| Q1 FY2020 | Mar 31, 2020 | $282.94M | +145.5% |
| Q4 FY2019 | Dec 31, 2019 | $306.21M | +160.6% |
| Q3 FY2019 | Sep 30, 2019 | $310.08M | +161.7% |
| Q2 FY2019 | Jun 30, 2019 | $205.27M | +71.2% |
| Q1 FY2019 | Mar 31, 2019 | $115.23M | -5.8% |
| Q4 FY2018 | Dec 31, 2018 | $117.52M | -11.9% |
| Q3 FY2018 | Sep 30, 2018 | $118.50M | -11.3% |
| Q2 FY2018 | Jun 30, 2018 | $119.89M | -10.8% |
| Q1 FY2018 | Mar 31, 2018 | $122.30M | -7.9% |
| Q4 FY2017 | Dec 31, 2017 | $133.38M | -3.5% |
| Q3 FY2017 | Sep 30, 2017 | $133.66M | +388.1% |
| Q2 FY2017 | Jun 30, 2017 | $134.38M | – |
| Q1 FY2017 | Mar 31, 2017 | $132.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $138.16M | – |
| Q3 FY2016 | Sep 30, 2016 | $27.38M | – |
See a number that looks wrong?